These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35925352)

  • 1. [Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy].
    Helmers G; Munteanu C; Löw U; Seitz B
    Ophthalmologie; 2023 Jan; 120(1):20-26. PubMed ID: 35925352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.
    Sen M; Midha N; Sidhu T; Angmo D; Sihota R; Dada T
    Ophthalmol Glaucoma; 2018; 1(2):88-98. PubMed ID: 32677614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
    Johnson MS; Sarkisian SR
    J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
    Senthil S; Rao HL; Babu JG; Mandal AK; Garudadri CS
    Indian J Ophthalmol; 2013 Jul; 61(7):338-42. PubMed ID: 23571259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
    Castejón MA; Teus MA; Bolivar G; Paz-Moreno-Arrones J; Castaño B
    J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.
    Khairy MA; Kenawy S; Fawzi KM; Al-Nashar HY
    Int Ophthalmol; 2023 May; 43(5):1591-1600. PubMed ID: 36266601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
    Shalaby HS; Hashem NH
    Klin Monbl Augenheilkd; 2022 Sep; 239(9):1147-1154. PubMed ID: 34198351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis.
    He M; Wang W; Zhang X; Huang W
    PLoS One; 2014; 9(1):e85782. PubMed ID: 24465704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of the Use of Ologen in Filtering Surgery Performed in Uncontrolled Glaucoma.
    Navero-Rodríguez JM; Boldú-Roig J; Pinilla L; Vidal-Martí M; Antón A
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124730
    [No Abstract]   [Full Text] [Related]  

  • 10. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
    Cillino S; Di Pace F; Cillino G; Casuccio A
    Eye (Lond); 2011 Dec; 25(12):1598-606. PubMed ID: 21921953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trabeculectomy with Ologen® implant and bevacizumab].
    Glandorf K; Lommatzsch C; Heinz C; Koch JM
    Ophthalmologe; 2020 May; 117(5):445-451. PubMed ID: 31541288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
    Salimi A; Kovalyuk N; Harasymowycz PJ
    J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety].
    Lommatzsch C; Heinz C; Rothaus K; Koch JM
    Klin Monbl Augenheilkd; 2020 Jan; 237(1):62-70. PubMed ID: 30736077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification.
    Paul C; Divya J; Kamal R; Paul A
    Indian J Ophthalmol; 2022 Apr; 70(4):1248-1252. PubMed ID: 35326026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phacotrabeculectomy using collagen matrix implant (Ologen
    Wlaź A; Wilkos-Kuc A; Rozegnał-Madej A; Żarnowski T
    Acta Ophthalmol; 2019 Sep; 97(6):e817-e826. PubMed ID: 30924600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma.
    Marey HM; Mandour SS; Ellakwa AF
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):330-4. PubMed ID: 23113645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study.
    El-Sayyad F; El-Saied HMA; Abdelhakim MASE
    Ophthalmic Res; 2017; 57(4):230-238. PubMed ID: 28291960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
    Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
    BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials.
    Ji Q; Qi B; Liu L; Guo X; Zhong J
    J Glaucoma; 2015; 24(5):e88-94. PubMed ID: 25264995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Ologen implant and different concentrations of Mitomycin C as an adjuvant to trabeculectomy surgery.
    Eldaly ZH; Maasoud AA; Saad MS; Mohamed AA
    Oman J Ophthalmol; 2017; 10(3):184-192. PubMed ID: 29118494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.